Total Payments
$5,256
2024 Payments
$1,383
Companies
28
Transactions
221
Medicare Patients
1,854
Medicare Billing
$203,062
Payment Breakdown by Category
Food & Beverage$4,344 (82.6%)
Travel$804.78 (15.3%)
Education$107.25 (2.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,344 | 215 | 82.6% |
| Travel and Lodging | $804.78 | 4 | 15.3% |
| Education | $107.25 | 2 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Olympus Corporation of the Americas | $991.73 | 6 | $0 (2019) |
| ABBVIE INC. | $589.72 | 38 | $0 (2024) |
| Janssen Biotech, Inc. | $552.18 | 27 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $496.75 | 36 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $461.39 | 25 | $0 (2024) |
| Axonics, Inc. | $203.11 | 5 | $0 (2023) |
| Braintree Laboratories, Inc. | $187.73 | 10 | $0 (2024) |
| Merck Sharp & Dohme LLC | $179.57 | 5 | $0 (2023) |
| Ferring Pharmaceuticals Inc. | $159.58 | 8 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $152.51 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,383 | 73 | ABBVIE INC. ($243.25) |
| 2023 | $663.69 | 40 | Janssen Biotech, Inc. ($129.37) |
| 2022 | $1,297 | 76 | ABBVIE INC. ($227.13) |
| 2021 | $365.29 | 18 | Janssen Biotech, Inc. ($172.45) |
| 2020 | $22.35 | 1 | Boston Scientific Corporation ($22.35) |
| 2019 | $438.32 | 7 | Merck Sharp & Dohme Corporation ($138.71) |
| 2018 | $961.10 | 5 | Olympus Corporation of the Americas ($920.32) |
| 2017 | $124.97 | 1 | Janssen Scientific Affairs, LLC ($124.97) |
All Payment Transactions
221 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $31.85 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/27/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: LIVER DISEASE | ||||||
| 11/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/20/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: LIVER DISEASE | ||||||
| 11/18/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $31.92 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.12 | General |
| 11/11/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: GI COLON PREP | ||||||
| 11/06/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.37 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/28/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/16/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $13.38 | General |
| Category: GI | ||||||
| 10/14/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: GI COLON PREP | ||||||
| 10/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/30/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: LIVER DISEASE | ||||||
| 09/30/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $12.03 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Gastroenterology | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Immunology | ||||||
| 09/23/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: VIROLOGY | ||||||
| 09/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 648 | 1,265 | $228,985 | $66,120 |
| 2022 | 15 | 961 | 2,191 | $334,085 | $108,558 |
| 2021 | 10 | 245 | 418 | $73,150 | $28,384 |
Total Patients
1,854
Total Services
3,874
Medicare Billing
$203,062
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 92 | 394 | $29,550 | $11,842 | 40.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 53 | 53 | $50,350 | $10,302 | 20.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 91 | $14,105 | $7,840 | 55.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 76 | 76 | $15,580 | $7,567 | 48.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 62 | 67 | $33,500 | $6,079 | 18.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 54 | 54 | $40,500 | $4,204 | 10.4% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 36 | 148 | $7,400 | $3,330 | 45.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 27 | $5,130 | $2,990 | 58.3% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 44 | 100 | $8,000 | $2,846 | 35.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $9,800 | $2,002 | 20.4% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 48 | 176 | $4,400 | $1,748 | 39.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 12 | $3,000 | $1,598 | 53.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $2,590 | $1,299 | 50.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $2,550 | $1,277 | 50.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 22 | $2,530 | $1,197 | 47.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 140 | 681 | $51,075 | $21,991 | 43.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 128 | 128 | $26,240 | $14,665 | 55.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 56 | 56 | $53,200 | $11,022 | 20.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 97 | 105 | $52,500 | $10,289 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 91 | 118 | $18,290 | $10,224 | 55.9% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2022 | 80 | 226 | $18,080 | $7,166 | 39.6% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 68 | 247 | $12,350 | $6,379 | 51.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 72 | 72 | $54,000 | $5,618 | 10.4% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2022 | 86 | 381 | $9,525 | $4,372 | 45.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 29 | $5,510 | $4,051 | 73.5% |
About Linda Yan
Linda Yan is a Gastroenterology healthcare provider based in Hazle Township, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2015. The National Provider Identifier (NPI) number assigned to this provider is 1437544467.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Linda Yan has received a total of $5,256 in payments from pharmaceutical and medical device companies, with $1,383 received in 2024. These payments were reported across 221 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($4,344).
As a Medicare-enrolled provider, Yan has provided services to 1,854 Medicare beneficiaries, totaling 3,874 services with total Medicare billing of $203,062. Data is available for 3 years (2021–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Hazle Township, PA
- Active Since 04/06/2015
- Last Updated 08/04/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1437544467
Products in Payments
- EVIS EXERA (Device) $1,033
- XIFAXAN (Drug) $452.08
- ENTYVIO (Biological) $376.39
- STELARA (Biological) $300.96
- REMICADE (Biological) $260.46
- CREON (Drug) $208.76
- Axonics (Device) $203.11
- DUPIXENT (Biological) $181.00
- DIFICID (Drug) $165.82
- Linzess (Drug) $152.51
- INJECTAFER (Drug) $132.95
- SUCRAID (Drug) $131.69
- SUFLAVE (Drug) $120.34
- TREMFYA (Drug) $115.73
- LINZESS (Drug) $104.42
- JAGWIRE (Device) $95.25
- IBSRELA (Drug) $94.74
- RINVOQ (Biological) $88.03
- Talicia (Drug) $84.98
- REBYOTA (Biological) $79.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.